<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38351">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01712022</url>
  </required_header>
  <id_info>
    <org_study_id>200-48071</org_study_id>
    <nct_id>NCT01712022</nct_id>
  </id_info>
  <brief_title>Evaluation of Corneal Epithelial Thickness Mapping</brief_title>
  <official_title>Evaluation of Corneal Epithelial Thickness Mapping</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optovue</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optovue</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optovue has developed a new feature for mapping corneal epithelial thickness.  The purpose
      of the study is to evaluate the accuracy and repeatability of the epithelial thickness
      measurement. Consented subjects will undergo a series of cornea measurements using optical
      coherence tomography (OCT) that will be used for analysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>corneal epithelial thickness</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">59</enrollment>
  <condition>Dry Eye and Contact Lens Wear</condition>
  <arm_group>
    <arm_group_label>Dry Eye</arm_group_label>
    <description>clinical diagnosis of dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Contact Lens</arm_group_label>
    <description>routine wear of contact lens</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        seeing eye doctor for routine or follow-up care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  Able and willing to provide consent

          -  Able and willing to complete the required examinations

          -  DRY EYE GROUP ONLY:  Clinical diagnosis of dry eye

          -  CONTACT LENS GROUP ONLY: Regular contact lens wear

        Exclusion Criteria:

          -  History of ocular surgery

          -  History of laser refractive surgery

          -  History of cataract surgery

          -  DRY EYE GROUP ONLY:  Corneal pathology not associated with dry eye

          -  CONTACT LENS GROUP ONLY:  Corneal pathology including dry eye
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fishman Vision</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gordon-Weiss-Schanzlin Vision Institute</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brass Eye Center</name>
      <address>
        <city>Latham</city>
        <state>New York</state>
        <zip>12110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>March 8, 2013</lastchanged_date>
  <firstreceived_date>October 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
